Skin Disease for Clinicians

About this session:

Victoria Werth, M.D., will discuss the identification and treatment of skin manifestations associated with dermatomyositis, including diagnostic criteria, various skin manifestations, and the latest treatment approaches and insights into the complexities of managing dermatomyositis, aiming to improve patient outcomes and quality of life.

About Dr. Werth:

Dr. Werth is a Professor of Dermatology and Medicine at the University of Pennsylvania School of Medicine and Chief of the Division of Dermatology at the Philadelphia Veterans Administration Hospital. Dr. Werth earned her medical degree from Johns Hopkins University School of Medicine in Baltimore, Maryland. Her professional achievements include being recognized for her groundbreaking research in autoimmune skin diseases, particularly in the areas of lupus and dermatomyositis. She has also published extensively in top-tier medical journals, presented her work at major scientific conferences, and received numerous awards and honors for her contributions to dermatology and autoimmune diseases.

optimizing-care-turnier-web

Pioneering JM Care – Integrating Research With a Multidisciplinary Approach to Care

Dr. Jessica Turnier of the University of Michigan / Mott’s Children’s Hospital is dedicated to creating new directions for JM research and wider perspectives on how it is treated. About the University of Michigan, she states, “When I came to Michigan, there were a lot of myositis patients, and I just developed a really strong connection with those patients.”

Quarterly Medical News Web Size Image

Quarterly JM Medical News

The Cure JM Foundation produces a quarterly newsletter with the latest news, educational opportunities, and research updates about Juvenile Myositis.

Understanding Second line treatments and side effects

Understanding Second-Line Treatments and Side Effects

Second-line treatments refer to options beyond steroids and methotrexate. They are designed to manage JM while reducing reliance on those medications. We understand that adding new treatments to your child’s regimen can be intimidating. However, rest assured that your doctor has carefully considered the benefits and risks of each option to design the best treatment plan for your family.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.